KKR backs mon­ster $300M raise to build up a new-mod­el biotech — de­signed by Neil Ku­mar and MIT’s An­drew Lo

Neil Ku­mar al­ways want­ed to build a dif­fer­ent kind of biotech com­pa­ny at Bridge­Bio. And now the CEO has banked right un­der $300 mil­lion to con­tin­ue con­struc­tion work on the grand de­sign as he thinks about grow­ing the pipeline and start­ing their first mar­ket­ing ef­forts.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER